Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrated DNA Technologies (IDT) is a global leader in the manufacturing of custom nucleic acid products, serving the academic research, biotechnology, clinical diagnostics, and pharmaceutical development sectors. The company is a premier supplier of synthetic DNA and RNA oligonucleotides, CRISPR genome editing reagents, and tools for Next-Generation Sequencing (NGS) and synthetic biology. IDT is widely recognized for its 'IDT Spectrum' line of proprietary fluorescent dyes, which are essential for molecular probes and diagnostic assays like fluorescence in situ hybridization (FISH). Since its acquisition by Danaher Corporation in 2018 for approximately $1.9 billion, IDT has operated as a key component of Danaher's Life Sciences segment, supporting genomic innovation worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IDT Spectrum.